Unlocking the antidiabetic potential of novel pyrazole-triazole hybrids through synthesis, dual α-amylase/α-glucosidase inhibition, multiscale biological evaluation, and molecular dynamics studies

January 1, 2026RSC AdvancesOpen Access

View Full Paper

Ask AI

Bookmark

Share

Key Points

The research focuses on developing effective antidiabetic agents using a new pyrazole-based scaffold.
Designed novel pyrazole-linked carbohydrazide compounds.
Evaluated dual inhibition of α-amylase and α-glucosidase activities.
Conducted multiscale biological evaluations and molecular dynamics studies.
Identified strong inhibition of α-amylase and α-glucosidase activities by the novel compounds.
Demonstrated enhanced potential for these agents in managing diabetes through structural evaluations.
Molecular dynamics indicated favorable interactions with target enzymes.

Reveals antidiabetic effects of pyrazole-triazole hybrids in biological evaluations, indicating their potential for diabetes treatment.

This study aimed to design potent antidiabetic agents based on a pyrazole-linked carbohydrazide scaffold.

No takes yet. Share an insight, caveat, or question.

Fakhry et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Share